Five Japanese Pharmas License Ariadne's Pathway Software | GenomeWeb
NEW YORK (GenomeWeb News) - Ariadne said today it has recently licensed its Pathway Studio Enterprise software to five Japanese pharmaceutical companies through its distribution partner World Fusion.
The software is used to analyze data from microarray, proteomics, and other experiments and is supported by the company’s Resnet mammalian and plant databases.
Ariadne said World Fusion has been distributing its products in Japan since 2004.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.